MedPath

Clinical predictors of recurrence and malignization of Oral Leukoplakia and Proliferative Verrucous Leukoplakia: a randomized clinical trial

Not Applicable
Recruiting
Conditions
eukoplakia
Registration Number
RBR-4v36p2h
Lead Sponsor
niversidade Estadual de Campinas
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

We will select 60 patients diagnosed with oral leukoplakia (OL) and 60 patients with proliferative verrucous leukoplakia (PVL) through biopsy and histological analysis. Only patients presenting with OL and PVL located in any region in the oral cavity will be selected. It is estimated that the participants will be mostly male smokers over 50 years of age for the diagnosis of OL and non-smoking women over 60 years of age for the diagnosis of PVL.

Exclusion Criteria

We will excluded patients with a history of previous oral carcinomas, chemotherapy, or radiation therapy in the head and neck region.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath